Lung Cancer

Lung Cancer News

  • Expanded Palliative Care for All NSCLC Patients Expanded Palliative Care for All NSCLC Patients An ASCO provisional clinical opinion recommends that all patients with metastatic nonsmall-cell lung cancer (NSCLC) be offered palliative care concurrent with standard therapy, starting at diagnosis.
    Medscape Medical News, February 7, 2012
  • Added Thalidomide Unhelpful in NSCLC Thalidomide should not be added to standard chemoradiotherapy for inoperable non-small cell lung cancer (NSCLC), randomized trial results show.
    Reuters Health Information, February 6, 2012
More
 

Lung Cancer Perspectives

  • Lung Tumor Grows, but Must Chemo Change? Lung Tumor Grows, but Must Chemo Change?   Dr. Mark Kris discusses cancer progression, as defined by RECIST criteria, and the situations in which increased tumor size in NSCLC need not prompt a change in standard chemotherapy.
    Medscape Hematology-Oncology, February 3, 2012
  • Bevacizumab: Important Drug for NSCLC Bevacizumab: Important Drug for NSCLC   Dr. Mark Kris highlights the therapeutic benefits -- and toxicities -- associated with bevacizumab use in patients with non-small cell lung cancer.
    Medscape Hematology-Oncology, January 30, 2012
More
 

Journals

More
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC. This website also contains material copyrighted by 3rd parties.